Baumgartner H, Falk V, Bax JJ, et al; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391. PubMed PMID: 28886619.
Nishimura RA, Otto CM, Bonow RO, et al; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 10;129(23):e521-643. doi: 10.1161/CIR.0000000000000031. Epub 2014 Mar 3. Erratum in: Circulation. 2014 Sep 23;130(13):e120. Dosage error in article text. Circulation. 2014 Jun 10;129(23):e651. PubMed PMID: 24589853.
Baumgartner H, Bonhoeffer P, De Groot NM, et al; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010 Dec;31(23):2915-57. doi: 10.1093/eurheartj/ehq249. Epub 2010 Aug 27. PubMed PMID: 20801927.
Definition, Etiology, Clinical FeaturesTop
Mixed aortic stenosis (AS) and aortic regurgitation (AR) refers to concomitant stenosis and regurgitation of the aortic valve.
Etiology: Congenital (most commonly a bicuspid aortic valve), degenerative, rheumatic disease, prior balloon valvuloplasty for AS in childhood, or prior mediastinal irradiation.
Clinical features are similar to other types of acquired aortic valve disease and depend on the dominant lesion (AS vs AR). The coexisting AR causes a louder systolic murmur by increasing transvalvular flow across the stenotic valve.
1. Surgery: The decision is made on an individual basis, taking into consideration the symptoms, transvalvular gradient, aortic valve area, and left ventricular size and function.
Indications: In patients with dominant stenosis, even if the symptoms are mild; in patients with dominant regurgitation in the case of severe symptoms or reduced left ventricular ejection fraction. In patients with postradiation disease, the most common indication for surgery is concomitant coronary artery disease.
2. Pharmacotherapy: Depends on the dominant lesion. Note that vasodilators used for AR may increase the transvalvular gradient of AS; agents that slow the heart rate (beta-blockers) may increase regurgitant volumes in AR.
3. Prevention of infective endocarditis: see Infective Endocarditis.